ReVision Optics announced that 1,000 Raindrop Near Vision Inlay procedures have been performed since the company’s commercial launch of the product in late August 2016. The Raindrop Near Vision Inlay is a novel corneal inlay for the surgical correction of presbyopia, which is a natural part of the aging process that decreases the ability of the eye to focus on near objects.
“It’s exciting to reach this milestone, moreover within 8 months of our commercial launch. It’s even more exciting to improve the lives of those who previously struggled with everyday tasks like reading menus or seeing items on their smartphones,” John Kilcoyne, ReVision Optics’ President and Chief Executive Officer, said in a company news release. “More Americans are seeking out options to reduce the hassle of reading glasses by correcting presbyopia through outpatient procedures. The Raindrop Inlay is clearly a terrific option for those patients wanting to improve near vision and live life with a full range of vision.
“We are delighted with the reception our Raindrop Inlay has received from the ophthalmic community,” said Mr. Kilcoyne. “We now have 90+ surgeons performing the procedure and are processing requests for training daily. Results of our monthly survey for March 2017 of surgeons performing the procedure are typical of the responses we’ve received to date, with 100% indicating they would likely recommend the procedure to another surgeon and 94% saying they were satisfied with patient outcomes following the procedure.”
The Raindrop is a clear, biocompatible inlay that is placed in the non-dominant eye in a 10-minute outpatient procedure. The inlay is about the size of a pinhead and is less than half the thickness of a human hair. It mimics the properties of the natural cornea and changes the central curvature of the eye to improve near vision. ReVision Optics is commercializing the Raindrop Near Vision Inlay through a comprehensive marketing campaign and a commercial sales organization comprised of sales representatives and clinical outcomes specialists.
ReVision Optics also announced plans to participate in two upcoming ophthalmic conferences.
- Mr. Kilcoyne will participate on a panel reviewing the scope of disruptive presbyopia technologies and their current market penetration at the Ophthalmic Innovation Summit (OIS) on May 4, 2017. The conference, which is expected to be attended by approximately 700 clinicians, industry representatives and investors, will be held at the Sheraton in downtown Los Angeles.
- ReVision Optics will showcase the Raindrop Near Vision Inlay on the exhibition floor at the joint American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) Symposium & Congress being held May 5-9, at the Los Angeles Convention Center. The ASCRS ASOA Symposium and Congress is expected to be the largest U.S. meeting integrating a scientific program dedicated to the needs of the anterior segment specialist with the leading practice management program for comprehensive ophthalmology and subspecialties. The ReVision Optics’ display will be at booth #2936.